Shionogi & Co., Ltd. - Unsponsored ADR (SGIOY)
OTC
Closed
Aug 24, 2026
Day's Range
9.1452 wk Range
7.65Overview - SGIOY - Shionogi & Co., Ltd. - Unsponsored ADR
Key Statistics
Valuation
Enterprise Value
2.52B
P/E (Trailing)
‪12.07‬
P/E (Forward)
‪3.71‬
PEG Ratio
‪0.14‬
Price / Sales (TTM)
‪0.02‬
Price / Book
‪1.39‬
EV / EBITDA
‪2.66‬
Profitability
Profit Margin
‪46.78%‬
Operating Margin
‪11.41%‬
Return on Assets
‪3.21%‬
Return on Equity
‪16.77%‬
Ownership
Shares Outstanding
1.70B
Float
1.70B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.01%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪8.81‬
200-Day Avg
‪9.54‬
Dividends
Payout Ratio
‪28.65%‬
Frequency
Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SGIOY - Shionogi & Co., Ltd. - Unsponsored ADR
Peers - SGIOY - Shionogi & Co., Ltd. - Unsponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - SGIOY - Shionogi & Co., Ltd. - Unsponsored ADR
About
Shionogi & Co., Ltd. – Unsponsored ADR is a financial instrument representing shares of Shionogi & Co., Ltd., a Japanese pharmaceutical company, available in the form of American Depositary Receipts (ADRs) to U.S. investors. This unsponsored ADR allows investors to gain exposure to Shionogi’s global operations without…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
